Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
230.00    9.00 (4.07%)
Bid:
217.00
Ask:
229.00
Spread: 12.00 (5.53%)
Market Cap: £121.43m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Director/PDMR Shareholding

22 Oct 2015 07:01

RNS Number : 0341D
Microgen PLC
22 October 2015
 



22 October 2015

The following share options have been awarded to the following persons discharging managerial responsibilities/directors:

NOTIFICATION OF TRANSACTIONS OF DIRECTORS / PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

 

1.

Name of the issuer

2.

State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance with section 793 of the Companies Act 2006, or (iii) in accordance with paragraph 26 of the Model Code

MICROGEN PLC

(i)

3.

Name of person discharging managerial responsibilities/director

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

PHILIP WOOD

N/A

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

N/A

N/A

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

8

State the nature of the transaction

N/A

N/A

9.

Number of shares, debentures or financial instruments relating to shares acquired

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

N/A

N/A

11.

Number of shares, debentures or financial instruments relating to shares disposed

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

N/A

N/A

13.

Price per share or value of transaction

14.

Date and place of transaction

N/A

N/A

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

16.

Date issuer informed of transaction

N/A

N/A

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17

Date of grant

18.

Period during which or date on which it can be exercised

21 OCTOBER 2015

21 OCTOBER 2018 TO 21 OCTOBER 2025

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

NIL

150,000 ORDINARY SHARES OF 6 3/7 PENCE EACH UNDER THE MICROGEN PERFORMANCE SHARE PLAN 2006

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22.

Total number of shares or debentures over which options held following notification

6 3/7 PENCE

650,000

23.

Any additional information

24.

Name of contact and telephone number for queries

INFORMATION IS BASED ON THE COMPANY’S CURRENT ISSUED SHARE CAPITAL WHICH IS 58,060,521

PHILIP WOOD, GROUP FINANCE DIRECTOR, MICROGEN PLC â€" 020 7496 8100

              Â

 

 

1.

Name of the issuer

2.

State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance with section 793 of the Companies Act 2006, or (iii) in accordance with paragraph 26 of the Model Code

MICROGEN PLC

(i)

3.

Name of person discharging managerial responsibilities/director

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

SIMON BAINES

N/A

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

N/A

N/A

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

8

State the nature of the transaction

N/A

N/A

9.

Number of shares, debentures or financial instruments relating to shares acquired

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

N/A

N/A

11.

Number of shares, debentures or financial instruments relating to shares disposed

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

N/A

N/A

13.

Price per share or value of transaction

14.

Date and place of transaction

N/A

N/A

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

16.

Date issuer informed of transaction

N/A

N/A

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17

Date of grant

18.

Period during which or date on which it can be exercised

21 OCTOBER 2015

21 OCTOBER 2018 TO 21 OCTOBER 2025

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

NIL

150,000 ORDINARY SHARES OF 6 3/7 PENCE EACH UNDER THE MICROGEN PERFORMANCE SHARE PLAN 2006

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22.

Total number of shares or debentures over which options held following notification

6 3/7 PENCE

650,000

23.

Any additional information

24.

Name of contact and telephone number for queries

INFORMATION IS BASED ON THE COMPANY’S CURRENT ISSUED SHARE CAPITAL WHICH IS 58,060,521

PHILIP WOOD, GROUP FINANCE DIRECTOR, MICROGEN PLC â€" 020 7496 8100

 

 

 

1.

Name of the issuer

2.

State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance with section 793 of the Companies Act 2006, or (iii) in accordance with paragraph 26 of the Model Code

MICROGEN PLC

(i)

3.

Name of person discharging managerial responsibilities/director

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

TOM CRAWFORD

N/A

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

N/A

N/A

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

8

State the nature of the transaction

N/A

N/A

9.

Number of shares, debentures or financial instruments relating to shares acquired

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

N/A

N/A

11.

Number of shares, debentures or financial instruments relating to shares disposed

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

N/A

N/A

13.

Price per share or value of transaction

14.

Date and place of transaction

N/A

N/A

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

16.

Date issuer informed of transaction

N/A

N/A

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17

Date of grant

18.

Period during which or date on which it can be exercised

21 OCTOBER 2015

21 OCTOBER 2018 TO 21 OCTOBER 2025

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

NIL

500,000 ORDINARY SHARES OF 6 3/7 P EACH UNDER THE MICROGEN PERFORMANCE SHARE PLAN 2006

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22.

Total number of shares or debentures over which options held following notification

6 3/7 PENCE

650,000

23.

Any additional information

24.

Name of contact and telephone number for queries

INFORMATION IS BASED ON THE COMPANY’S CURRENT ISSUED SHARE CAPITAL WHICH IS 58,060,521

PHILIP WOOD, GROUP FINANCE DIRECTOR, MICROGEN PLC â€" 020 7496 8100

 

 

 

1.

Name of the issuer

2.

State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance with section 793 of the Companies Act 2006, or (iii) in accordance with paragraph 26 of the Model Code

MICROGEN PLC

(i)

3.

Name of person discharging managerial responsibilities/director

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

ANJUM O’NEILL

N/A

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

N/A

N/A

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

8

State the nature of the transaction

N/A

N/A

9.

Number of shares, debentures or financial instruments relating to shares acquired

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

N/A

N/A

11.

Number of shares, debentures or financial instruments relating to shares disposed

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

N/A

N/A

13.

Price per share or value of transaction

14.

Date and place of transaction

N/A

N/A

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

16.

Date issuer informed of transaction

N/A

N/A

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17

Date of grant

18.

Period during which or date on which it can be exercised

21 OCTOBER 2015

21 OCTOBER 2018 TO 21 OCTOBER 2025

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

NIL

25,000 ORDINARY SHARES OF 6 3/7 P EACH UNDER THE MICROGEN PERFORMANCE SHARE PLAN 2006

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22.

Total number of shares or debentures over which options held following notification

6 3/7 PENCE

125,000

23.

Any additional information

24.

Name of contact and telephone number for queries

INFORMATION IS BASED ON THE COMPANY’S CURRENT ISSUED SHARE CAPITAL WHICH IS 58,060,521

PHILIP WOOD, GROUP FINANCE DIRECTOR, MICROGEN PLC â€" 020 7496 8100

 

Name and signature of duly authorised officer of issuer responsible for making notification

PHILIP WOOD, GROUP FINANCE DIRECTOR, MICROGEN PLC

Date of notification:  22 October 2015

www.microgen.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSPGGMGUUPAGQG
Date   Source Headline
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20263:10 pmRNSNotification of Major Holdings
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20262:10 pmRNSNotification of Major Holdings
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSFY25 Trading Update and Notice of Results
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 202611:34 amRNSNotification of Major Holdings
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20262:36 pmRNSNotification of Major Holdings
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20262:25 pmRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20263:33 pmRNSTotal Voting Rights
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSNotification of Major Holdings
29th Dec 20257:00 amRNSNotification of Major Holdings
29th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
24th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.